2631-60-9

Usage

Uses

Used in Pharmaceutical Synthesis:
1-(2,4-dichlorophenyl)-3-(dimethylamino)propan-1-one is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the formation of complex organic molecules that are vital in medicinal chemistry.
Used in Organic Compound Synthesis:
In the field of organic chemistry, 1-(2,4-dichlorophenyl)-3-(dimethylamino)propan-1-one is used as a building block for the creation of a variety of organic compounds, leveraging its unique structural features to form new chemical entities.
Used in Chemical Research:
1-(2,4-dichlorophenyl)-3-(dimethylamino)propan-1-one is utilized as a reagent in chemical research, particularly in studies aimed at understanding reaction mechanisms and developing new synthetic methodologies.
Used in Biochemistry:
In biochemistry, 1-(2,4-dichlorophenyl)-3-(dimethylamino)propan-1-one may be employed in the development of new biochemical assays or as a component in the study of enzyme mechanisms, given its potential to interact with biological systems.
Used in Chemical Industry:
1-(2,4-dichlorophenyl)-3-(dimethylamino)propan-1-one is used in the chemical industry for the production of various specialty chemicals that require its specific structural attributes.

Upstream product

• 50-00-0 formaldehyd 
• 506-59-2 N,N-dimethylammonium chloride 
• 2234-16-4 1-(2,4-dichlorophenyl)ethan-1-one 

Downstream Products

• 1253195-93-5 1-thiocarbamoyl-3-(2,4-dichlorophenyl)-4,5-dihydropyrazole 
• 95886-33-2 2-Chloro-6-(2,4-dichloro-phenyl)-3-(2-methyl-5-nitro-phenyl)-3,4-dihydro-[1,3,2]oxazaphosphinine 2-oxide 
• 95886-37-6 2-Chloro-6-(2,4-dichloro-phenyl)-3-(4-methoxy-phenyl)-3,4-dihydro-[1,3,2]oxazaphosphinine 2-oxide 
• 95886-35-4 2-Chloro-3-(4-chloro-phenyl)-6-(2,4-dichloro-phenyl)-3,4-dihydro-[1,3,2]oxazaphosphinine 2-oxide 
• 95886-36-5 2-Chloro-6-(2,4-dichloro-phenyl)-3-p-tolyl-3,4-dihydro-[1,3,2]oxazaphosphinine 2-oxide 
• 95886-34-3 2-chloro-6-(2,4-dichlorophenyl)-3-phenyl-3,4-dihydro-1,3,2-oxazaphosphorin-2-oxide 
• 81234-40-4 3-(1H-1,2,4-triazol-1-yl)-1-(2,4-dichlorophenyl)propan-1-one 

Relevant academic research and scientific papers

Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase

Some differently substituted 3-aryl-4,5-dihydropyrazoles-1-carbothioamides have been synthesised with the aim to investigate their monoamine oxidase inhibitory activity. The chemical structures of the compounds have been characterized by means of their IR, 1H NMR, 13C NMR spectroscopic data and elemental analyses. All the active compounds showed a selective activity towards the B isoform of the enzyme, regardless of the substitution on the heterocyclic ring. The inhibition of the enzymatic activity was measured on human recombinant MAO isoforms, expressed in baculovirus infected BTI insect cells. Docking experiments were carried out with the aim to rationalize the mechanism of inhibition of the most active and selective compound.

Synthesis, structure characterization, and biological evaluation of some new 1,2,3-benzotriazole derivatives

Ten novel benzotriazole compounds were synthesized. Their chemical structures were confirmed by 1H NMR, IR, and elemental analyses, coupled with three selected single-crystal structures (compounds A2, B3, and B5). Their antimycotic and antitumor activities were also investigated. The title compounds showed some antitumor activities, especially in the case of A3 and A4, which showed the most potent activity of propagation inhibition in liver and galactophore cancer cells. Birkhaueser Boston 2009.

Synthesis of Heterocyclic Compounds: Part XXVIII - Potential Antileukemic Agents from 3,4-Dihydro-1,3,2-oxazaphosphorin-2-oxides

Some 3,6-diaryl-2-chloro-3,4-dihydro-1,3,2-oxazaphosphorin-2-oxides (4a-q, 6a-e and 7a, b) have been synthesised and tested for their anti-leukemic activity.